Article

Impact of Neoadjuvant Chemotherapy on the Association between Key Genetic Alterations and Tumor Microenvironment in Upper Tract Urothelial Carcinoma

2026-06-11

Abstract excerpt

<title>Abstract</title> <p> <bold>Background and Objective:</bold> Adjuvant nivolumab has demonstrated clinical benefit in urothelial carcinoma; however, emerging evidence suggests that its efficacy may differ between bladder cancer and upper tract urothelial carcinoma (UTUC), potentially reflecting differences in genomic profiles and the tumor microenvironment (TME). This study aimed to evaluate the associatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: abbcba6b-f628-5c68-b272-61996e972e98
DOI: 10.21203/rs.3.rs-9899413/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of Neoadjuvant Chemotherapy on the Association between Key Genetic Alterations and Tumor Microenvironment in Upper Tract Urothelial CarcinomaDOI 10.21203/rs.3.rs-9899413/v1Read

Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations.Semantic proximity Read

Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity Read

Novel Use of ctDNA to Identify Muscle-Invasive and Non-Organ Confined Upper Tract Urothelial CarcinomaSemantic proximity Read

Current Knowledge on Genomic Profiling of Upper Tract Urothelial CarcinomaSemantic proximity Read

Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial CarcinomaSemantic proximity Read

Prognostic Impact of APOBEC3B Expression for Tumor-infiltrating Cytotoxic T cells in Metastatic Urothelial CarcinomaSemantic proximity Read

Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study.Semantic proximity Read

Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.Semantic proximity Read

Novel molecular biomarkers to guide treatment-decision making in metastatic urothelial cancer - A patient cohort analysisSemantic proximity Read

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma.Semantic proximity Read

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signalingSemantic proximity Read

RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.Semantic proximity Read